Delivery Order SPE2DP20D0002-SPE2DP20F7226
Award Date 9/21/20
Potential Completion Date 9/29/20
Potential Value $136K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a $282,353.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This award is not associated with a set-aside contract. Teva Pharmaceuticals has a history of providing pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal customers such as...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide Adenovirus Type 4 vaccine. The $135,747.00 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva has received numerous awards from the Defense Logistics Agency and Department of Veterans Affairs to supply vaccines, antiviral medications, respiratory...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed price delivery order to Teva Pharmaceuticals USA, Inc. for the supply of Adenovirus Type 4 vaccine. The $271,494.00 contract has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that provides a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal agencies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm fixed-price delivery order (SPE2DP24F7177) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This order is part of a larger Indefinite Delivery Contract (SPE2DP20D0002) held by Teva to provide essential medications to federal agencies such as the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. for the supply of Adenovirus Type 4 vaccine. The award has a potential value of $135,747.00 and a completion date of June 23, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has provided a range of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 award is to provide Adenovirus Type 4 vaccine, with an ultimate completion date of March 26, 2024. Teva Pharmaceuticals USA is an experienced federal contractor, having been awarded numerous prime contracts and delivery orders by agencies such as the Department of Veterans...
- The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP20F7226Delivery Order
Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, was awarded a $135,747 delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Adenovirus Type 4 vaccine. The order has a completion date of September 29, 2020 and was issued under a firm-fixed price contract. Teva is an experienced provider of pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal agencies such as the Department of Defense and Department of Veterans Affairs. This award is not associated with a set-aside program.
Generated 3/23/24, 1:52 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $135.7k | 9/21/20 |